MO530: Daprodustat is not Associated With an Increased Risk of Cancer: Results From the ASCEND-D and ASCEND-ND Trials
Author(s) -
Ajay Singh,
Christoph Wanner,
Andrzej Jan Wiecek,
Allison Blackorby,
Tara Barker,
Amy M. Meadowcroft,
Alexander R. Cobitz
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac072.012
Subject(s) - medicine , cancer , erythropoietin , kidney disease , anemia , prostate cancer , clinical trial , population , adverse effect , dialysis , kidney cancer , oncology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom